02:08 PM EDT, 08/25/2025 (MT Newswires) -- HCW Biologics ( HCWB ) said Monday its scientists have developed a second-generation, pembrolizumab-based immunotherapeutics against solid tumors, especially for pancreatic and ovarian cancer, using its TRBC platform.

Shares surged 58% as intraday trading volume soared to more than 82.5 million from a daily average of about 133,000.

Sharps Technology ( STSS ) said Monday it has priced a private placement of stock and warrants to raise over $400 million to establish a Solana digital asset treasury strategy.

Shares soared 67% as intraday trading volume catapulted to over 22.4 million from a daily average of roughly 925,000.

Immuneering ( IMRX ) said it struck a clinical supply deal with Eli Lilly (LLY) to assess atebimetinib in combination with olomorasib in a phase 2 trial in patients with advanced non-small cell lung cancer. Atebimetinib is Immuneering's ( IMRX ) lead drug candidate.

Shares rose 14%, with intraday trading volume of over 1.95 million against a daily average of about 1.39 million.

Price: 5.45, Change: +2.00, Percent Change: +57.93